TIM S.A. SPON ADS EACH REP 5 ORD SHS TIMB 深 沪
等待开盘 12-18 09:30:00 美东时间
20.68
-0.130
-0.62%
华盛通- 最 高20.95
- 今 开20.71
- 成交量 12.95万股
- 最 低 20.64
- 昨 收 20.81
- 总市值 99.68亿
- 52周最高 23.875
- 市盈率 静 17.11
- 换手率 0.03%
- 52周最低 10.0826
- 委 比 33.33%
- 总股本 4.82亿
- 历史最高 23.875
- 量 比 0.52
- 振 幅 1.49%
- 历史最低 6.1285
- 每 手 1
- 风险率 4.02%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多TIM S.A. Expands B2B Strategy with Acquisition of V8.Tech
TIM ( ($TIMB) ) has shared an update. On November 27, 2025, TIM S.A. announced ...
11-28 19:48
美股盘后 | 思科涨7.49%，Revolution Medicines涨3.30%
思科涨7.49%；Revolution Medicines涨3.30%；Royalty pharma plc涨2.85%
11-13 07:11
TIM S.A. Reinforces Regulatory Compliance with SEC Filing
The latest update is out from TIM ( ($TIMB) ). On November 10, 2025, TIM S.A. s...
11-11 06:27
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 10:22
美股盘后 | Expedia Group涨15.00%，Affirm涨14.04%
Expedia Group涨15.00%；Affirm涨14.04%；SanDisk Corporation涨7.85%
11-07 07:12
美股大行评级 | 最高325美元！10家机构集体上调AMD目标价；Pinterest遭14家大行下调目标价；大行对优步目标价分歧大，5家下调5家上调
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从3美元升至9美元；HC Wainwright & Co.：上调CervoMed评级至"买入"，目标价从11美元升至25美元
11-06 09:55
HSBC Upgrades TIM to Buy, Raises Price Target to $27
HSBC analyst Phani Kanumuri upgrades TIM (NYSE:TIMB) from Hold to Buy and raises the price target from $21 to $27.
11-05 21:13
TIM S.A. Reports Q3 2025 Financial Results
TIM ( ($TIMB) ) just unveiled an update. On November 3, 2025, TIM S.A. released...
11-04 19:29
TIM Q3 Adj. EPS $0.46 Beats $0.36 Estimate, Sales $1.232B Miss $1.250B Estimate
TIM (NYSE:TIMB) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.36 by 27.78 percent. This is a 53.33 percent increase over earnings of $0.30 per share from the same period
11-04 06:12
